Pancreatic Cancer Research

ResearcherUniversity of FreiburgNo recent work listed

Jan Harder

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5113453226. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2011: 1 paper · 2012: 2 papers

Papers 3

  1. Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer. Co-author DOI 10.1038/bjc.2012.18↗
  2. Early recurrence of pancreatic cancer after resection and during adjuvant chemotherapy. Last author DOI 10.4103/1319-3767.93815↗
  3. KRAS mutation in metastatic pancreatic ductal adenocarcinoma: results of a multicenter phase II study evaluating efficacy of cetuximab plus gemcitabine/oxalipl… Co-author DOI 10.1159/000330194↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Esther Endlicher · 2 shared papers, 2011–2012 · strength 0.05
  2. Christian Lohrmann · 1 shared paper, 2012 · strength 0.04
  3. Matthias Breidert · 1 shared paper, 2012 · strength 0.04
  4. Tobias Keck · 1 shared paper, 2012 · strength 0.04
  5. Markus Hermann Moehler · 1 shared paper, 2012 · strength 0.03
  6. Ralf‐Dieter Hofheinz · 1 shared paper, 2012 · strength 0.03
  7. Christoph Röcken · 1 shared paper, 2012 · strength 0.03
  8. Michael Geißler · 1 shared paper, 2012 · strength 0.03
  9. Volker Heinemann · 1 shared paper, 2012 · strength 0.03
  10. Anke Reinacher‐Schick · 1 shared paper, 2012 · strength 0.03
  11. Stefan Hubert Boeck · 1 shared paper, 2012 · strength 0.03
  12. Frank Kullmann · 1 shared paper, 2011 · strength 0.02
  13. Jörg Trojan · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.